|
RRN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.399560E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.758910E-03 |
| Normal-vs-Stage2 |
7.249000E-01 |
| Normal-vs-Stage3 |
2.020400E-04 |
| Normal-vs-Stage4 |
6.837600E-04 |
| Stage1-vs-Stage2 |
1.661650E-02 |
| Stage1-vs-Stage3 |
1.587590E-01 |
| Stage1-vs-Stage4 |
3.672400E-01 |
| Stage2-vs-Stage3 |
3.862400E-03 |
| Stage2-vs-Stage4 |
1.439810E-02 |
| Stage3-vs-Stage4 |
8.589000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.819200E-04 |
| Normal-vs-AfricanAmerican |
1.971810E-01 |
| Normal-vs-Asian |
9.184300E-03 |
| Caucasian-vs-AfricanAmerican |
2.556400E-01 |
| Caucasian-vs-Asian |
6.434400E-01 |
| AfricanAmerican-vs-Asian |
4.478000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.191300E-04 |
| Normal-vs-Female |
3.656500E-03 |
| Male-vs-Female |
3.252400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.620800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.944600E-03 |
| Normal-vs-Age(61-80Yrs) |
9.162700E-03 |
| Normal-vs-Age(81-100Yrs) |
5.483800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.879800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.675200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.306000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.393200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.793800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.622400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.992000E-01 |
| Classical-VS-Follicular |
8.538100E-02 |
| Classical-VS-Other |
4.370600E-01 |
| Classical-VS-Normal |
2.020000E-03 |
| Tall-VS-Follicular |
4.328400E-02 |
| Tall-VS-Other |
7.103600E-01 |
| Tall-VS-Normal |
3.178700E-03 |
| Follicular-VS-Other |
2.308200E-01 |
| Follicular-VS-Normal |
2.331400E-01 |
| Other-VS-Normal |
4.527900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.835900E-03 |
| Normal-vs-N1 |
7.83790000000728E-05 |
| N0-vs-N1 |
8.714500E-02 |
|
|
